Effects of an NMDA-receptor antagonist MK-801 on an MMN-like response recorded in anesthetized rats

Dmitry Tikhonravov1, Tuomas Neuvonen, Antti Pertovaara

  • 1Neuroscience Unit, Institute of Biomedicine/Physiology, University of Helsinki, Finland; Helsinki Brain Research Center, Finland.

Brain Research
|March 8, 2008
PubMed

Insights

Auditory sensory memory, measured by mismatch negativity (MMN), relies on N-methyl-d-aspartate (NMDA) receptors in rats. Blocking NMDA receptors with MK-801 dose-dependently inhibited the MMN-like response in this study.

Area of Science:

  • Neuroscience
  • Auditory Perception
  • Neuropharmacology

Background:

  • Auditory sensory memory in humans is studied via mismatch negativity (MMN), an event-related potential linked to auditory and frontal cortices.
  • Cortical N-methyl-d-aspartate (NMDA) receptors are crucial for MMN generation in monkeys.
  • MMN-like responses have been observed in rats, suggesting conserved neural mechanisms.

Purpose of the Study:

  • To investigate the role of the NMDA-receptor system in generating MMN-like responses in rats.
  • To determine if NMDA receptor blockade affects MMN-like responses in the rat auditory system.

Main Methods:

  • Auditory evoked responses were recorded epidurally in anesthetized rats using an oddball paradigm.
  • Rats received intraperitoneal injections of either saline or the NMDA-receptor antagonist MK-801.
  • The effect of MK-801 on the MMN-like response was assessed in a dose-dependent manner.

Main Results:

  • An MMN-like response was successfully recorded in saline-treated rats during the oddball paradigm.
  • Administration of MK-801 resulted in a dose-dependent blockade of the MMN-like response.
  • The findings indicate a significant impact of NMDA receptor antagonism on the MMN-like response.

Conclusions:

  • The MMN-like response in rats is dependent on an intact NMDA-receptor system.
  • This study supports the involvement of NMDA receptors in auditory sensory memory processing across species.
  • NMDA receptor antagonists represent a potential pharmacological tool to modulate MMN-like responses in preclinical models.

Related Concept Videos